InsiderClue
← All stocks

Contineum Therapeutics, Inc.

CTNM Scheduled selling only
CIK 0001855175 #2951 in the set updated 17 Sep 2026
Bought (120 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$1.98M
$502.61K on a plan · $1.47M straight out of an exercise
Sold at will
$0.00
0 of 34 sales
Net
−$1.98M
$0.00 against sales at will

By person

5 insiders · 35 transactions
0.4×

Carmine N. Stengone holds only 0.4 times base salary in stock. $283.33K of shares against $655.62K in salary for 2025.

Salary from the company's own proxy. The shares are what Carmine N. Stengone last reported holding, valued at $16.46, the price Class A Common Stock was last bought or sold at on the open market here, on 8 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Lorrain Daniel S.
Chief Scientific Officer
—
$1.25M (22) scheduled
−$1.25M
135,202
0.5853%
$2.22M
−23.1%
Stengone Carmine N.
CEO and President
—
$401.38K (7) scheduled
−$401.38K
17,217
0.0745%
$283.33K
0.0%
Watkins Tim
CMO & Head of Development
—
$322.56K (5) scheduled
−$322.56K
8,961
0.0388%
$147.47K
0.0%
Versant Venture Capital VI, L.P. entity
10% owner
—
—
—
148,312
0.6421%
$2.44M
—
Huhn Stephen L.
CMO & Sr VP, Clinical Dev.
—
—
—
12,800
0.0554%
$210.64K
—

Individual transactions

13
Insider
Date
Role
Action
Shares
Price
Amount
Lorrain Daniel S.
1 Jun 2026
Chief Scientific Officer
Sold on a plan
4,170
$13.16
$54.86K
Lorrain Daniel S.
1 May 2026
Chief Scientific Officer
Sold on a plan
300
$13.84
$4.15K
Lorrain Daniel S.
1 May 2026
Chief Scientific Officer
Sold on a plan
3,870
$13.06
$50.54K
Lorrain Daniel S.
6 Apr 2026
Chief Scientific Officer
Sold on a plan
4,170
$13.43
$56.01K
Lorrain Daniel S.
2 Mar 2026
Chief Scientific Officer
Sold on a plan
4,170
$15.01
$62.59K
Lorrain Daniel S.
3 Feb 2026
Chief Scientific Officer
Sold on a plan
1,170
$15.25
$17.84K
Lorrain Daniel S.
3 Feb 2026
Chief Scientific Officer
Sold on a plan
3,000
$14.82
$44.47K
Lorrain Daniel S.
5 Jan 2026
Chief Scientific Officer
Sold on a plan
500
$11.13
$5.56K
Lorrain Daniel S.
5 Jan 2026
Chief Scientific Officer
Sold on a plan
3,670
$10.35
$37.98K
Lorrain Daniel S.
23 Dec 2025
Chief Scientific Officer
Sold on a plan
4,170
$12.23
$51.01K
Lorrain Daniel S.
25 Nov 2024
Chief Scientific Officer
Sold on a plan
1,010
$16.02
$16.18K
Lorrain Daniel S.
18 Nov 2024
Chief Scientific Officer
Sold on a plan
99
$17.05
$1.69K
Lorrain Daniel S.
18 Nov 2024
Chief Scientific Officer
Sold on a plan
6,091
$16.37
$99.73K
Show all 35 transactions →

What was left out

Form 4 filings counted 63
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 21
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 644,767
History held since 11 Apr 2024